According to the study, the drug improved recovery time and decreased the number of deaths.
NEJM publishes results of remdesivir, COVID-19 trial conducted by UT Health San Antonio, University HospitalMay 28, 2020
SAN ANTONIO (May 29, 2020) — San Antonio patients with severe COVID-19 lung disease contributed to an international study published May 22 in the New England Journal of Medicine. The study outlined preliminary results of the recent Adaptive Covid-19 Treatment Trial, conducted partly in San Antonio, testing a new anti-viral drug called remdesivir. Thomas Patterson, […]
UT Teen Health, an adolescent health and wellness program of UT Health San Antonio, has been reaching out to the community during the COVID-19 pandemic.
SAN ANTONIO (May 26, 2020) — New mothers who have returned to using opioids or have died of an overdose often have a troubled past going back to their childhood. The death of a parent, abuse by a trusted individual, the routine use of drugs in the home or problems with relationships later as an […]
Mays Cancer Center experts to discuss why getting screenings now is important during May 29 webinar SAN ANTONIO (May 22, 2020) — Studies have shown that individuals with cancer who get COVID-19 are more likely to have poor outcomes. And with everyone staying home during the pandemic, many people have missed their regular cancer screenings. […]
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.